Rosario
Palacios Muñoz
Publicaciones en las que colabora con Rosario Palacios Muñoz (15)
2021
-
Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?
International Journal of STD and AIDS, Vol. 32, Núm. 13, pp. 1257-1260
-
Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain
HIV Medicine, Vol. 22, Núm. 5, pp. 379-386
-
Kinetics of emergence of liver complications in hepatitis C virus infected patients and advanced fibrosis, with and without HIV-coinfection, after sustained virological response
AIDS (London, England), Vol. 35, Núm. 13, pp. 2119-2127
-
Progression to hepatitis C virus micro-elimination in people living with HIV in Spain
Clinical Microbiology and Infection
2020
-
Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 71, Núm. 9, pp. 2354-2362
-
Using machine learning methods to determine a typology of patients with HIVHCV infection to be treated with antivirals
PLoS ONE, Vol. 15, Núm. 1
-
What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: A modeling analysis
BMC Infectious Diseases, Vol. 20, Núm. 1
2019
-
Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients
Journal of Viral Hepatitis, Vol. 26, Núm. 1, pp. 48-54
-
Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR
Scientific Reports, Vol. 9, Núm. 1
-
Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks
Journal of Infection, Vol. 79, Núm. 1, pp. 30-35
-
Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy
Journal of Hepatology, Vol. 71, Núm. 1, pp. 45-51
-
Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection
Journal of Viral Hepatitis, Vol. 26, Núm. 1, pp. 16-24
2018
-
Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice
HIV Clinical Trials, Vol. 19, Núm. 1, pp. 23-30
-
Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis
Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 9, pp. 2435-2443
2016
-
Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 2, pp. 357-361